RS
Rob Sprawson
OtherActivePartner & CFO at Cambridge Innovation Capital
31
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Rob Sprawson.
Investment Thesis & Strategy
Rob Sprawson, as a partner at Cambridge Innovation Capital, invests in various stages of AI/ML, Biotech, Diagnostics, Healthcare, and Fintech companies, likely seeking innovative and high-growth potential ventures.
Investment Activity
Deals per year over the last 4 years
7
20161
20172
20181
2019Portfolio Companies
Selected investments from their portfolio of 31 companies
F
Fluidic Analytics
Biotech · Series B, 0
A
AudioTelligence
AI/ML · Seed, 2019
E
Exvastat
Biotech · Seed, 2018
S
Sense Biodetection
Biotech · Series A, 2018
R
Riverlane
AI/ML · Series A, 2017
P
PredictImmune
Biotech · Series A, 2016
C
Carrick Therapeutics
Biotech · Series A, 2016
I
Imagen Ltd
AI/ML · Seed, 2016
S
Secondmind
AI/ML · Series A, 2016
P
PolyProx
Biotech · Seed, 2016
S
Storm Therapeutics
Biotech · Series A, 2016
M
Microbiotica
Biotech · Series A, 2016
Frequently Asked Questions
Rob Sprawson focuses on Seed, Series A stage investments.